MedtronicMDT stock dropped Tuesday after announcing a series of board appointments to appease activist investor Elliott Management.The company appointed John Groetelaars and Bill Jellison to the board ...

Preliminary data are expected this year for a Phase 1/2 clinical trial testing the investigational therapy SRP-1003 in DM1.

Learn more about whether ADMA Biologics, Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...

Viking Therapeutics stock crashed Tuesday — losing more than a third of its value — on mixed results for its weight-loss pill ...